Catheter Precision Inc (VTAK)
0.508
+0.02
(+3.97%)
USD |
NYAM |
Nov 01, 16:00
0.5108
0.00 (0.00%)
After-Hours: 20:00
Catheter Precision Enterprise Value: 2.058M for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 2.058M |
| October 31, 2024 | 2.004M |
| October 30, 2024 | 2.064M |
| October 29, 2024 | 2.178M |
| October 28, 2024 | 2.21M |
| October 25, 2024 | 2.373M |
| October 24, 2024 | 3.089M |
| October 23, 2024 | 2.86M |
| October 22, 2024 | 3.186M |
| October 21, 2024 | 3.200M |
| October 18, 2024 | 3.186M |
| October 17, 2024 | 1.870M |
| October 16, 2024 | 1.843M |
| October 15, 2024 | 1.68M |
| October 14, 2024 | 1.616M |
| October 11, 2024 | 1.616M |
| October 10, 2024 | 1.629M |
| October 09, 2024 | 1.547M |
| October 08, 2024 | 1.556M |
| October 07, 2024 | 1.575M |
| October 04, 2024 | 1.647M |
| October 03, 2024 | 1.647M |
| October 02, 2024 | 1.659M |
| October 01, 2024 | 1.722M |
| September 30, 2024 | 1.742M |
| Date | Value |
|---|---|
| September 27, 2024 | 1.844M |
| September 26, 2024 | 1.828M |
| September 25, 2024 | 1.946M |
| September 24, 2024 | 2.128M |
| September 23, 2024 | 1.921M |
| September 20, 2024 | 1.896M |
| September 19, 2024 | 1.938M |
| September 18, 2024 | 1.890M |
| September 17, 2024 | 1.864M |
| September 16, 2024 | 1.896M |
| September 13, 2024 | 1.839M |
| September 12, 2024 | 1.823M |
| September 11, 2024 | 1.746M |
| September 10, 2024 | 1.761M |
| September 09, 2024 | 1.797M |
| September 06, 2024 | 1.761M |
| September 05, 2024 | 1.896M |
| September 04, 2024 | 1.982M |
| September 03, 2024 | 2.042M |
| August 30, 2024 | 1.218M |
| August 29, 2024 | 1.979M |
| August 28, 2024 | 2.384M |
| August 27, 2024 | 2.473M |
| August 26, 2024 | 2.483M |
| August 23, 2024 | 2.493M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-38.63M
Minimum
Dec 17 2019
5.064M
Maximum
Jun 30 2024
-14.07M
Average
-14.02M
Median
Feb 09 2022
Enterprise Value Benchmarks
| Plus Therapeutics Inc | 2.817M |
| Perspective Therapeutics Inc | 524.04M |
| Retractable Technologies Inc | -19.02M |
| InfuSystems Holdings Inc | 170.22M |
| Xtant Medical Holdings Inc | 102.06M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.22M |
| Revenue (Quarterly) | 0.093M |
| Total Expenses (Quarterly) | 2.81M |
| EPS Diluted (Quarterly) | -5.57 |
| Gross Profit Margin (Quarterly) | 82.80% |
| Profit Margin (Quarterly) | -4.54K% |
| Earnings Yield | 25.59% |
| Normalized Earnings Yield | 25.59 |